Brain-type Natriuretic Peptide (BNP) and Cardiovascular Risk in Children
Authors:
M. Mráz 1; M. Urbanová 2; P. Wohlfahrt 2; Ľ. Podracká 1
Authors‘ workplace:
I. Klinika detí a dorastu LF UPJŠ a DFN, Košice
prednostka prof. MUDr. Ľ. Podracká, CSc.
1; Lekárska fakulta UPJŠ, Košice
2
Published in:
Čes-slov Pediat 2006; 61 (2): 89-94.
Category:
Comprehensive Report
Overview
Increased plasmatic concentration of brain-type natriuretic peptide (BNP) is a sensitive and specific marker of left ventricular dysfunction in adults with cardiovascular diseases. However, such data in children are lacking. Authors of the review focus on the relationship between BNP concentration in plasma and cardiovascular morbidity in children at risk.
Key words:
brain-type natriuretic peptide, cardiovascular risk, children
Labels
Neonatology Paediatrics General practitioner for children and adolescentsArticle was published in
Czech-Slovak Pediatrics
2006 Issue 2
Most read in this issue
- Care of the Newborns on the Waves of Time or View to the History of the Neonatology
- Neonatal Hyperekplexia
- Procalcitonin – its Present Position in the Diagnosis and Prognosis of Inflammation A review
- Brain-type Natriuretic Peptide (BNP) and Cardiovascular Risk in Children